Skip to main content
SG

Sisu Global Health

Sisu Global has developed Hemafuse, a handheld autotransfusion device that enables clinicians to salvage, filter, and re-transfuse a patient's own blood during surgeries involving internal bleeding. This technology addresses the global blood shortage by providing immediate access to blood transfusions, significantly reducing reliance on donor blood.

Baltimore, United StatesFounded 201491K+ followers
Updated 4 months ago

Funding

$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Globally, there is a critical shortage of donor blood, leaving many clinicians without the necessary resources for life-saving transfusions during surgeries involving internal bleeding. This shortage disproportionately affects resource-limited settings, where access to donor blood is often unreliable or nonexistent.

Solution

Sisu Global's Hemafuse is a handheld autotransfusion device designed to address the global blood shortage by enabling clinicians to salvage, filter, and re-transfuse a patient's own blood during surgeries involving internal bleeding. This allows for immediate access to blood transfusions, reducing the reliance on scarce donor blood and providing a safe and readily available alternative. The device captures blood lost during surgery, filters it to remove contaminants, and returns the clean, whole blood back to the patient. Hemafuse can be used across various surgical procedures, including trauma, obstetric, general, and orthopedic surgeries.

Target Audience

The primary target audience includes clinicians, surgeons, and medical personnel in hospitals, clinics, and military settings, particularly in resource-limited environments where access to donor blood is constrained. Veterinarians can also use the device.

Features

  • Handheld, portable design for easy use in various clinical settings
  • Autotransfusion technology that salvages and re-transfuses a patient's own blood
  • Integrated filtration system to remove contaminants from salvaged blood
  • Immediate access to blood transfusions, reducing reliance on donor blood
  • Suitable for use in trauma, obstetric, general, and orthopedic surgeries
  • Training resources available, including online courses and videos
  • US FDA 510K clearance and regulatory clearance in Ghana, Kenya, India & Tanzania
  • ISO 13485 certified
This profile is AI-generated and may contain inaccuracies.